Nasdaq Stockholm

Hamlet BioPharma AB

ISIN SE0015661152Filings at the FI

At a glance

Most recent filing on May 25, 2026 — a sale by HS Compliance Partner AB on May 25, 2026.

We hold 8 visible filings, going back to January 18, 2022.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

Insider trades

What is a MAR filing?

5 of 8 shown

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings at this company, out of 8. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are the price history with every buy marked, the price change beside each line, and any moments with several buyers or buying streaks. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

HS Compliance Partner AB Closely associated: Board member
74,900 SEKOpen-market sale
TradedMay 25, 2026FiledMay 25, 2026
HS Compliance Partner AB Closely associated: Board member
76,100 SEKOpen-market sale
TradedMay 22, 2026FiledMay 25, 2026
HS Compliance Partner AB Closely associated: Board member
75,800 SEKOpen-market sale
TradedMay 22, 2026FiledMay 25, 2026
HS Compliance Partner AB Closely associated: Board member
153,000 SEKOpen-market sale
TradedMay 22, 2026FiledMay 25, 2026
HS Compliance Partner AB Closely associated: Board member
154,000 SEKOpen-market sale
TradedMay 22, 2026FiledMay 25, 2026